SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008174
Filing Date
2019-08-14
Accepted
2019-08-14 16:24:20
Documents
90
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20190630x10q.htm 10-Q 2891499
2 EX-10.6 jagx-20190630ex106ca3861.htm EX-10.6 67729
3 EX-31.1 jagx-20190630ex3117ae439.htm EX-31.1 12633
4 EX-31.2 jagx-20190630ex312723b12.htm EX-31.2 12546
5 EX-32.1 jagx-20190630ex3214f134f.htm EX-32.1 7926
6 EX-32.2 jagx-20190630ex32227c4ca.htm EX-32.2 7853
  Complete submission text file 0001558370-19-008174.txt   11886631

Data Files

Seq Description Document Type Size
7 EX-101.INS jagx-20190630.xml EX-101.INS 2253095
8 EX-101.SCH jagx-20190630.xsd EX-101.SCH 103536
9 EX-101.CAL jagx-20190630_cal.xml EX-101.CAL 54378
10 EX-101.DEF jagx-20190630_def.xml EX-101.DEF 543857
11 EX-101.LAB jagx-20190630_lab.xml EX-101.LAB 756411
12 EX-101.PRE jagx-20190630_pre.xml EX-101.PRE 725106
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 191026773
SIC: 2834 Pharmaceutical Preparations